Nephros Statistics
Total Valuation
Nephros has a market cap or net worth of $22.28 million. The enterprise value is $20.14 million.
Important Dates
The last earnings date was Thursday, May 8, 2025, after market close.
| Earnings Date | May 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Nephros has 10.60 million shares outstanding. The number of shares has increased by 1.85% in one year.
| Current Share Class | 10.60M |
| Shares Outstanding | 10.60M |
| Shares Change (YoY) | +1.85% |
| Shares Change (QoQ) | +0.57% |
| Owned by Insiders (%) | 12.80% |
| Owned by Institutions (%) | 44.14% |
| Float | 9.24M |
Valuation Ratios
The trailing PE ratio is 27.40 and the forward PE ratio is 330.16.
| PE Ratio | 27.40 |
| Forward PE | 330.16 |
| PS Ratio | 1.47 |
| Forward PS | 1.97 |
| PB Ratio | 2.46 |
| P/TBV Ratio | 2.87 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 25.15 |
| EV / Sales | 1.30 |
| EV / EBITDA | 22.15 |
| EV / EBIT | 26.09 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.92, with a Debt / Equity ratio of 0.14.
| Current Ratio | 5.92 |
| Quick Ratio | 4.45 |
| Debt / Equity | 0.14 |
| Debt / EBITDA | 0.90 |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 9.17% and return on invested capital (ROIC) is 4.71%.
| Return on Equity (ROE) | 9.17% |
| Return on Assets (ROA) | 4.16% |
| Return on Invested Capital (ROIC) | 4.71% |
| Return on Capital Employed (ROCE) | 7.52% |
| Revenue Per Employee | $500,548 |
| Profits Per Employee | $25,839 |
| Employee Count | 31 |
| Asset Turnover | 1.34 |
| Inventory Turnover | 2.46 |
Taxes
In the past 12 months, Nephros has paid $15,000 in taxes.
| Income Tax | 15,000 |
| Effective Tax Rate | 1.84% |
Stock Price Statistics
The stock price has increased by +5.37% in the last 52 weeks. The beta is 0.81, so Nephros's price volatility has been lower than the market average.
| Beta (5Y) | 0.81 |
| 52-Week Price Change | +5.37% |
| 50-Day Moving Average | 1.84 |
| 200-Day Moving Average | 1.69 |
| Relative Strength Index (RSI) | 60.78 |
| Average Volume (20 Days) | 7,353 |
Short Selling Information
The latest short interest is 8,083, so 0.08% of the outstanding shares have been sold short.
| Short Interest | 8,083 |
| Short Previous Month | 11,427 |
| Short % of Shares Out | 0.08% |
| Short % of Float | 0.09% |
| Short Ratio (days to cover) | 0.74 |
Income Statement
In the last 12 months, Nephros had revenue of $15.52 million and earned $801,000 in profits. Earnings per share was $0.08.
| Revenue | 15.52M |
| Gross Profit | 9.69M |
| Operating Income | 772,000 |
| Pretax Income | -1.29M |
| Net Income | 801,000 |
| EBITDA | 909,250 |
| EBIT | 772,000 |
| Earnings Per Share (EPS) | $0.08 |
Full Income StatementBalance Sheet
The company has $4.08 million in cash and $1.33 million in debt, giving a net cash position of $2.75 million or $0.26 per share.
| Cash & Cash Equivalents | 4.08M |
| Total Debt | 1.33M |
| Net Cash | 2.75M |
| Net Cash Per Share | $0.26 |
| Equity (Book Value) | 9.29M |
| Book Value Per Share | 0.88 |
| Working Capital | 7.47M |
Full Balance SheetCash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
Gross margin is 62.45%, with operating and profit margins of 4.98% and 5.16%.
| Gross Margin | 62.45% |
| Operating Margin | 4.98% |
| Pretax Margin | 5.26% |
| Profit Margin | 5.16% |
| EBITDA Margin | 5.86% |
| EBIT Margin | 4.98% |
| FCF Margin | n/a |
Dividends & Yields
Nephros does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.85% |
| Shareholder Yield | n/a |
| Earnings Yield | 3.50% |
| FCF Yield | n/a |
Analyst Forecast
The average price target for Nephros is $5.00, which is 137.85% higher than the current price. The consensus rating is "Buy".
| Price Target | $5.00 |
| Price Target Difference | 137.85% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on July 10, 2019. It was a reverse split with a ratio of 0.1111111:1.
| Last Split Date | Jul 10, 2019 |
| Split Type | Reverse |
| Split Ratio | 0.1111111:1 |
Scores
Nephros has an Altman Z-Score of -10.2 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -10.2 |
| Piotroski F-Score | 5 |